These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21172874)

  • 1. The role of osteoclast-associated receptor in osteoimmunology.
    Nemeth K; Schoppet M; Al-Fakhri N; Helas S; Jessberger R; Hofbauer LC; Goettsch C
    J Immunol; 2011 Jan; 186(1):13-8. PubMed ID: 21172874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclasts, rheumatoid arthritis, and osteoimmunology.
    Sato K; Takayanagi H
    Curr Opin Rheumatol; 2006 Jul; 18(4):419-26. PubMed ID: 16763464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis.
    Herman S; Müller RB; Krönke G; Zwerina J; Redlich K; Hueber AJ; Gelse H; Neumann E; Müller-Ladner U; Schett G
    Arthritis Rheum; 2008 Oct; 58(10):3041-50. PubMed ID: 18821671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
    Takayanagi H
    Nat Rev Immunol; 2007 Apr; 7(4):292-304. PubMed ID: 17380158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamic interplay between osteoclasts and the immune system.
    Nakashima T; Takayanagi H
    Arch Biochem Biophys; 2008 May; 473(2):166-71. PubMed ID: 18410741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
    Bar-Shavit Z
    Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopetroses and immunodeficiencies in humans.
    Villa A; Vezzoni P; Frattini A
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):421-7. PubMed ID: 17088646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoimmunology--the hidden immune regulation of bone.
    Caetano-Lopes J; Canhão H; Fonseca JE
    Autoimmun Rev; 2009 Jan; 8(3):250-5. PubMed ID: 18722561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.
    Gillespie MT
    Arthritis Res Ther; 2007; 9(2):103. PubMed ID: 17381830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis.
    Grevers LC; de Vries TJ; Vogl T; Abdollahi-Roodsaz S; Sloetjes AW; Leenen PJ; Roth J; Everts V; van den Berg WB; van Lent PL
    Arthritis Rheum; 2011 May; 63(5):1365-75. PubMed ID: 21337316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New immune connections in osteoclast formation.
    Takayanagi H
    Ann N Y Acad Sci; 2010 Mar; 1192():117-23. PubMed ID: 20392226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast differentiation antigen.
    Kukita T; Kukita A
    Histol Histopathol; 1996 Jul; 11(3):821-30. PubMed ID: 8839769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bone destruction and osteoimmunology.
    Takayanagi H
    J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR).
    Ishikawa S; Arase N; Suenaga T; Saita Y; Noda M; Kuriyama T; Arase H; Saito T
    Int Immunol; 2004 Jul; 16(7):1019-25. PubMed ID: 15184345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoimmunology-overview].
    Okamoto K; Takayanagi H
    Clin Calcium; 2012 Nov; 22(11):1641-9. PubMed ID: 23103807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.
    Kim JH; Kim K; Youn BU; Jin HM; Kim N
    Cell Signal; 2010 Sep; 22(9):1341-9. PubMed ID: 20466061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of osteoclast development by immunoglobulin-like receptors].
    Inui M; Takai T
    Clin Calcium; 2012 Nov; 22(11):1651-7. PubMed ID: 23103808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
    Tanaka Y
    Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.